✦ LIBER ✦

Randomized phase III trial compared cisplatin and irinotecan (CPT-P) versus cisplatin and vindesine (VDS-P) versus irinotecan alone (CPT) in patients with advanced non-small cell lung cancer (NSCLC) — The final report

✍ Scribed by Komiya, T; Fukuoka, M; Negoro, S; Masuda, N; Takada, Y; Sugiura, T; Ohashi, Y; Niitani, H

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The final results of a randomized phase

✍ Takiguchi, Y; Nagao, K; Nishiwaki, Y; Yokoyama, A; Saijo, N; Ohashi, Y; Niitani, 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 219 KB

Cisplatin (CDDP) and irinotecan (CPT-11)

✍ H. Kunitoh; N. Saijo; K. Nagao; Y. Ohashi; H. Niitani 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 350 KB

Phase III trial of paclitaxel (P), carbo

✍ Socinski, MA; Sandler, AB; Petit, RG; Steagall, A; Hanover, CK; Natale, RB; Mill 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 212 KB

A randomized phase III trial of docetaxe

✍ Y. Nishiwaki; H. Kunitoh; K. Noda; Y. Ichinose; N. Katakami; T. Sugiura; M. Kawa 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Randomized phase III trial of Taxol®/Car

✍ Rosell, R.; Gatzemeier, U.; Betticher, D.; Keppler, U.; Macha, H.N.; Pirker, R.; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 98 KB

Phase II study of an intensive single do

✍ Dómine, M; Cardenal, F; Massuti, B; Carrato, A; Felip, E; Garrido, P; Juan, O; A 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 141 KB